Y mAbs Therapeutics (YMAB) Insider Trading
- $20,618,215.91
- $60,561,376.55
- Sept. 16, 2024
- Thomas Gad
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
July 22, 2021 | CFO | 4,000 | $34.50 | Sell | $138,000.00 | |
July 22, 2021 | CFO | 4,000 | $34.50 | Sell | $138,000.00 | |
July 20, 2021 | Insider | 4,000 | $32.47 | Sell | $129,880.00 | |
July 6, 2021 | CFO | 4,000 | $34.15 | Sell | $136,600.00 | |
June 22, 2021 | CFO | 4,000 | $36.17 | Sell | $144,680.00 | |
June 14, 2021 | Insider | 4,000 | $35.80 | Sell | $143,200.00 | |
June 9, 2021 | Director | 116,700 | $36.19 | Sell | $4,223,373.00 | |
June 7, 2021 | Major Shareholder | 72,400 | $34.15 | Sell | $2,472,460.00 | |
June 4, 2021 | Major Shareholder | 3,841 | $34.03 | Sell | $130,709.23 | |
June 4, 2021 | CFO | 4,000 | $33.48 | Sell | $133,920.00 | |
June 3, 2021 | Director | 30,666 | $33.19 | Sell | $1,017,804.54 | |
June 1, 2021 | Director | 6,864 | $35.57 | Sell | $244,152.48 | |
May 28, 2021 | Insider | 4,000 | $36.95 | Sell | $147,800.00 | |
May 28, 2021 | Director | 25,000 | $36.34 | Sell | $908,500.00 | |
May 24, 2021 | CFO | 4,000 | $35.61 | Sell | $142,440.00 | |
April 26, 2021 | Insider | 7,000 | $27.96 | Sell | $195,720.00 | |
April 12, 2021 | Insider | 7,000 | $26.61 | Sell | $186,270.00 | |
March 15, 2021 | Insider | 7,000 | $36.79 | Sell | $257,530.00 | |
Jan. 19, 2021 | Insider | 7,000 | $46.51 | Sell | $325,570.00 | |
Jan. 19, 2021 | Director | 2,000 | $46.52 | Sell | $93,040.00 | |
Jan. 5, 2021 | Insider | 7,000 | $49.36 | Sell | $345,520.00 | |
Dec. 28, 2020 | Insider | 7,000 | $51.98 | Sell | $363,860.00 | |
Dec. 16, 2020 | Insider | 7,000 | $53.01 | Sell | $371,070.00 | |
Dec. 14, 2020 | Insider | 4,000 | $52.89 | Sell | $211,560.00 | |
Dec. 10, 2020 | Insider | 50,000 | $50.75 | Sell | $2,537,500.00 | |
Dec. 2, 2020 | CMO | 233 | $51.03 | Buy | $11,889.99 | |
Dec. 2, 2020 | CEO | 40,734 | $51.27 | Sell | $2,088,432.18 | |
Dec. 1, 2020 | Chairman | 4,000 | $51.42 | Sell | $205,680.00 | |
Nov. 17, 2020 | CMO | 1,464 | $45.74 | Buy | $66,963.36 | |
Nov. 3, 2020 | Director | 4,000 | $45.00 | Sell | $180,000.00 | |
Oct. 15, 2020 | Chairman | 4,000 | $39.15 | Sell | $156,600.00 | |
Oct. 1, 2020 | Chairman | 4,000 | $38.88 | Sell | $155,520.00 | |
Sept. 14, 2020 | Chairman | 22,569 | $41.00 | Sell | $925,329.00 | |
Sept. 11, 2020 | Chairman | 13,571 | $40.33 | Sell | $547,318.43 | |
Sept. 1, 2020 | Chairman | 4,000 | $41.60 | Sell | $166,400.00 | |
Aug. 17, 2020 | Chairman | 4,000 | $40.35 | Sell | $161,400.00 | |
Aug. 11, 2020 | Chairman | 37,000 | $40.06 | Sell | $1,482,220.00 | |
July 15, 2020 | Chairman | 4,000 | $40.06 | Sell | $160,240.00 | |
June 15, 2020 | Chairman | 4,000 | $43.45 | Sell | $173,800.00 | |
June 4, 2020 | Chairman | 4,000 | $41.61 | Sell | $166,440.00 | |
May 26, 2020 | VP | 50,000 | $39.38 | Sell | $1,969,000.00 | |
May 13, 2020 | CFO | 14,724 | $37.86 | Sell | $557,450.64 | |
May 13, 2020 | CEO | 60,846 | $37.75 | Sell | $2,296,936.50 | |
May 12, 2020 | VP | 20,000 | $39.19 | Sell | $783,800.00 | |
May 12, 2020 | Chairman | 50,000 | $39.04 | Sell | $1,952,000.00 | |
April 13, 2020 | Chairman | 4,000 | $29.43 | Sell | $117,720.00 | |
March 17, 2020 | CEO | 1,900 | $17.22 | Buy | $32,718.00 | |
March 16, 2020 | Chairman | 4,000 | $18.01 | Sell | $72,040.00 | |
Feb. 10, 2020 | Chairman | 4,000 | $33.03 | Sell | $132,120.00 | |
Jan. 27, 2020 | Chairman | 4,000 | $35.06 | Sell | $140,240.00 |
Insiders are both buying and selling Y mAbs Therapeutics stock.
The insider traders at Y mAbs Therapeutics are: Thomas Gad, Bo Kruse, Johan Wedell-Wedellsborg, Biotech Aps Wg, Vignesh Rajah, Pedro Claus Juan Moller-San, Mahiuddin Ahmed, David N Gill, James Healy, Ashu Tyagi, Gerard Ber, Joris Wilms, and Moller San Pedro Claus Juan
The most active insider trader at Y mAbs Therapeutics is Thomas Gad with 74 trades.
Thomas Gad has sold the most Y mAbs Therapeutics stock with a total value of $32,757,585.26.
Ashu Tyagi has bought the most Y mAbs Therapeutics stock with a total value of $13,765,568.00.
The most recent insider trade for Y mAbs Therapeutics was on Sept. 16, 2024.
The single biggest insider buy for Y mAbs Therapeutics was from James Healy with a total value of $8,000,000.00 on Sept. 21, 2018.
The single biggest insider sell for Y mAbs Therapeutics was from Thomas Gad with a total value of $6,472,500.00 on April 11, 2019.